Page last updated: 2024-10-21

5-hydroxydecanoate and Cerebral Infarction

5-hydroxydecanoate has been researched along with Cerebral Infarction in 1 studies

5-hydroxydecanoic acid: Potassium Channel Blocker; RN refers to parent cpd

Cerebral Infarction: The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mayanagi, K1
Gáspár, T1
Katakam, PV1
Busija, DW1

Other Studies

1 other study available for 5-hydroxydecanoate and Cerebral Infarction

ArticleYear
Systemic administration of diazoxide induces delayed preconditioning against transient focal cerebral ischemia in rats.
    Brain research, 2007, Sep-07, Volume: 1168

    Topics: Analysis of Variance; Animals; Anti-Arrhythmia Agents; Cerebral Infarction; Decanoic Acids; Diazoxid

2007